DLPIC
BIIB icon

Davide Leone & Partners Investment Company’s Biogen BIIB Stock Holding History

Davide Leone & Partners Investment Company’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-139,107
Closed -$32.4M – 16
2019
Q3 		$32.4M Buy
+139,107
New +$32.4M 5.82% 8

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Davide Leone & Partners Investment Company's BIIB Position: Q4 2019 in Review

Davide Leone & Partners Investment Company sold out of Biogen (BIIB) in Q4 2019, closing a stake of 139,107 shares — an estimated $32.4M sold.

Davide Leone & Partners Investment Company first reported a position in BIIB in Q3 2019 and held it in 1 quarter. The position peaked at $32.4M in Q3 2019. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • Davide Leone & Partners Investment Company reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
  • Davide Leone & Partners Investment Company sold 139,107 Biogen shares in Q4 2019, an estimated $32.4M.
  • Davide Leone & Partners Investment Company first reported a position in Biogen in Q3 2019 and held it in 1 quarter.
  • Davide Leone & Partners Investment Company's Biogen position peaked at $32.4M in Q3 2019.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Davide Leone & Partners Investment Company's 13F filing for Q4 2019, filed 14 Feb 2020.